Myriad Publishes myRisk Hereditary Cancer Study In Cancer By: Benzinga via Benzinga September 03, 2014 at 16:06 PM EDT Myriad Genetics, Inc. (Nasdaq: MYGN), today announced that the Myriad myRisk™ Hereditary Cancer test significantly improved the ... Read More >> Related Stocks: Myriad Genetics Inc